Ekso Bionics Holdings Q3 EPS $(0.24) Beats $(0.31) Estimate, Sales $4.61M Beat $4.50M Estimate
Portfolio Pulse from vinayak@benzinga.com
Ekso Bionics Holdings reported Q3 losses of $(0.24) per share, beating the analyst consensus estimate of $(0.31) by 22.58%. This is a 27.27% increase over losses from the same period last year. The company also reported quarterly sales of $4.61 million, beating the analyst consensus estimate of $4.50 million by 2.38%. This is a 38.39% increase over sales from the same period last year.
October 26, 2023 | 8:12 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Ekso Bionics reported better than expected Q3 earnings and sales, indicating a positive financial performance.
Ekso Bionics reported better than expected earnings and sales for Q3. This indicates a positive financial performance which could lead to an increase in the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100